|
| Press Releases |
|
 |
|
| Friday, August 1, 2025 |
|
|
云顶新耀宣布增加对I-Mab的战略投资 开发自研新一代肿瘤免疫疗法的全球价值 |
| 2025年8月1日，云顶新耀（股份代号：1952.HK）宣布进一步战略增持I-Mab公司股份，将向I-Mab公司投资3,090万美元（折合约2.426亿港元）。 more info >> |
|
| Friday, July 25, 2025 |
|
|
Everest Medicines Announces Share Placement to Raise Approximately HK$1,572.50 Million |
| Everest Medicines (HKEX 1952.HK, Everest or the " Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that it has entered into a placing and subscription agreement with the placing agents and its controlling shareholder, CBC Group (the "Sellers"), for a top-up placement of 22,561,000 shares to raise approximately HK$1,572.50 million, representing approximately 6.87% of the total number of Shares in issue as at the date of this announcement, and approximately 6.45% of the total number of Shares in issue. more info >> |
|
|
雲頂新耀宣布配售股份 擬集資約15.725億港元 |
| 雲頂新耀有限公司（HKEX1952.HK）是一家專注於創新藥研發、臨床開發、制造和商業化的生物制藥公司，今日宣布以先舊後新配售22,561,000股，集資約15.725億港元，發行股份數占現有股本約6.87%, 占經擴大後的總股數約6.43%。 more info >> |
|
|
云顶新耀宣布配售股份 拟集资约15.725亿港元 |
| 云顶新耀有限公司（HKEX1952.HK）是一家专注于创新药研发、临床开发、制造和商业化的生物制药公司，今日宣布以先旧后新配售22,561,000股，集资约15.725亿港元，发行股份数占现有股本约6.87%, 占经扩大后的总股数约6.43%。 more info >> |
|
| Tuesday, July 15, 2025 |
|
|
雲頂新耀股價創階段新高 通用型現貨腫瘤治療性疫苗EVM14「中美雙報」再釋mRNA平台潛力 |
| 今日雲頂新耀（01952.HK）股價表現亮眼，盤中最高價觸及73.4港元，再創新高。 more info >> |
|
|
云顶新耀股价创阶段新高 通用型现货肿瘤治疗性疫苗EVM14"中美双报"再释mRNA平台潜力 |
| 今日云顶新耀（01952.HK）股价表现亮眼，盘中最高价触及73.4港元，再创新高。 more info >> |
|
| Friday, July 4, 2025 |
|
|
Everest Medicines Unveils Breakthroughs in AI+mRNA Platform, Reinforces Global Leadership in Next-Gen mRNA Innovation |
| Everest Medicines (HKEX: 1952.HK) recently unveiled major breakthroughs in its proprietary AI-powered mRNA platform during its 2025 R&D Day held in Shanghai. The event showcased the company's progress in building a fully integrated and independently operated mRNA platform and highlighted significant breakthroughs across several pipeline programs in cancer and autoimmune diseases. more info >> |
|
|
雲頂新耀發佈AI+mRNA平台新突破 重塑中國mRNA國際競爭格局 |
| 近期，雲頂新耀（HKEX: 1952.HK）在上海成功舉辦「2025雲頂新耀mRNA創新技術平台研發日」，系統展示其自主構建的AI+mRNA平台的最新進展，以及多個管線項目在腫瘤及自身免疫疾病治療中的前沿突破。 more info >> |
|
|
云顶新耀发布AI+mRNA平台新突破 重塑中国mRNA国际竞争格局 |
| 近期，云顶新耀（HKEX: 1952.HK）在上海成功举办“2025云顶新耀mRNA创新技术平台研发日”，系统展示其自主构建的AI+mRNA平台的最新进展，以及多个管线项目在肿瘤及自身免疫疾病治疗中的前沿突破。 more info >> |
|
| Thursday, July 3, 2025 |
|
|
雲頂新耀公佈EVER001-1b/2a期階段性數據 專家看好其作為新一代BTK療法的潛力 |
| 7月1日，雲頂新耀（HKEX: 1952.HK）公佈其自主研發的共價可逆BTK抑制劑EVER001在治療原發性膜性腎病（pMN）的1b/2a期臨床研究中取得最新數據。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
鍋圈(2517.HK)核心經營利潤勁增 四店齊發驅動長期成長
Mar 17, 2026 20:30 HKT/SGT
|
|
|
锅圈(2517.HK)核心经营利润劲增 四店齐发驱动长期成长
Mar 17, 2026 20:24 HKT/SGT
|
|
|
TANAKA PRECIOUS METAL GROUP Provides Medals, Commemorative Items, and Trophies as Category Sponsor (Awards Ceremonies) for the LIGA.i Blind Soccer Top League 2025
Mar 17, 2026 21:00 JST
|
|
|
Eisai Established the Global Capability Centre in Visakhapatnam, India, to Standardize Global IT Infrastructure Operations and Digital Transformation
Mar 17, 2026 19:49 JST
|
|
|
Wintermar Reports Results for The Full Year Ended 31 December 2025
Mar 17, 2026 18:16: JST
|
|
|
陽光保險公佈2025年度業績：「新陽光策略」深化落地 書寫責任與擔當新篇
Mar 17, 2026 18:12 HKT/SGT
|
|
|
阳光保险公布2025年度业绩："新阳光战略"深化落地 书写责任与担当新篇
Mar 17, 2026 18:05 HKT/SGT
|
|
|
Founders Metals Added to GDXJ Index; Commences Drilling at Antino North
Mar 17, 2026 17:59 HKT/SGT
|
|
|
The Executive Centre (TEC) Advances Digital Transformation in Real Estate with AI Agent Integration
Mar 17, 2026 16:03 HKT/SGT
|
|
|
Wintermar Reports Results for the Year Ended 31 December 2025
Mar 17, 2026 15:36 HKT/SGT
|
|
|
三菱重工、無人機に搭載するミッション・オートノミーの開発で飛行実証に成功 米国Shield AI社と協業して、AI開発環境「Hivemind Enterprise」を活用
Mar 17, 2026 13:35: JST
|
|
|
Successful Flight Demonstration of Mission Autonomy Developed for Use in Unmanned Aerial Vehicles
Mar 17, 2026 14:11 JST
|
|
|
華營控股樂見「AI天秤系統」獲建造安全類別獎項 以創新科技推動工地安全高質量發展
Mar 17, 2026 12:14 HKT/SGT
|
|
|
The University of Tokyo and NEC conclude a Strategic Collaboration Agreement to promote a prosperous society where people and AI succeed together
Mar 17, 2026 12:34 JST
|
|
|
NVIDIA Taps 51WORLD as Global L4 Simulation Partner at GTC
Mar 17, 2026 11:02 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
